Skip Over Navigation Links
National Institutes of Health

Clinical Trials

Post-Traumatic Stress Disorder (PTSD)

Featured Studies

Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the registry, with the most recent studies appearing first.

  • Evaluating the Effects of Stress in Pregnancy.
    Evaluation study. This study will evaluate pregnant women with a past or current diagnosis of depression or anxiety to gain a better understanding of how these disorders can affect an infant's development, both during and after pregnancy. Ages 18-45. Location in Atlanta, GA.
  • Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder.
    Interventional study. This study, conducted at the NIH and the Mount Sinai School of Medicine, will examine the effectiveness of a substance P or NK1 antagonist study drug known as GR205171 in treating the symptoms of posttraumatic stress disorder (PTSD). Ages 18-65. Locations in Bethesda, MD; New York, NY.
  • Effect of Propranolol on Preventing Post-Traumatic Stress Disorder.
    Interventional study. This study will assess the effectiveness of taking propranolol soon after a traumatizing incident in reducing the incidence and severity of post-traumatic stress disorder in acutely traumatized individuals. Ages 18-55. Location in Boston, MA.
  • Brain Function in Mentally Ill Adolescents.
    Evaluation study. The purpose of this study is to use brain imaging technology to examine the brain activity of adolescents with post-traumatic stress disorder (PTSD) and/or major depressive disorder (MDD) before and after treatment. Ages 7-18. Locations in Newark, DE; Bethesda, MD.

Search for other NIH studies on Post-Traumatic Stress Disorder (PTSD).